MOUNTAIN VIEW, Calif., September 04, 2025--(BUSINESS WIRE)--Aerin Medical Inc., a leader in minimally invasive solutions for chronic nasal conditions, today announced the publication of long-term ...

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Aerin Medical Inc., a company dedicated to providing Ear, Nose and Throat (ENT) physicians with non-invasive solutions for the treatment of chronic nasal ...

MOUNTAIN VIEW, Calif., June 27, 2025--(BUSINESS WIRE)--Aerin Medical Inc., a leader in minimally invasive solutions for chronic nasal conditions, today announced that Cigna Healthcare will provide ...

SUNNYVALE, Calif.--(BUSINESS WIRE)--Aerin Medical Inc., a company that provides Ear, Nose and Throat (ENT) physicians with non-invasive solutions to treat chronic nasal conditions, today announced the ...

Aerin Medical Inc., an Austin, Texas-based company focused on minimally invasive solutions for chronic nasal conditions, has won U.S. FDA clearance for the Rhinaer Stylus to treat chronic rhinitis.

Please provide your email address to receive an email when new articles are posted on . The RhinAer system generates and applies 4 W of 60°C temperature-controlled bipolar radiofrequency energy to the ...

Aerin Medical Inc., an Austin, Texas-based company focused on minimally invasive solutions for chronic nasal conditions, has won U.S. FDA clearance for the Rhinaer Stylus to treat chronic rhinitis.

Please provide your email address to receive an email when new articles are posted on . Temperature-controlled radiofrequency neurolysis of the posterior nasal nerve improved the symptom burden and ...

Aerin Medical Inc., a leader in minimally invasive solutions for chronic nasal conditions, today announced the publication of long-term results from a multicenter study evaluating the safety and ...

RhinAer provides ENT physicians with a comprehensive solution for the treatment of chronic rhinitis, addressing sources of rhinorrhea and congestion. The procedure can be performed with a local ...

Aerin Medical Inc., a leader in minimally invasive solutions for chronic nasal conditions, today announced the publication of long-term results from a multicenter study evaluating the safety and ...